INTEGRA’s commitment to developing greener labs
INTEGRA Biosciences has created a list of key steps to control laboratory resource consumption and waste production in an attempt to reduce environmental footprint
INTEGRA Biosciences has created a list of key steps to control laboratory resource consumption and waste production in an attempt to reduce environmental footprint
Nobelpharma will use ProBioGen’s cell-based production platform AGE1.CR.pIX to develop their lead vaccine
Project supports Croda’s global Research & Development Digital Program across all R&D locations
Molecular Cartography platform features leading microscopy and 3D imaging capabilities
Vaccine aims to combat numerous HIV strains, a key requirement of any vaccine to end the HIV/AIDs epidemic
Johan Engström, Senior Scientist at Gyros Protein Technologies, discusses the challenges of measuring high-affinity interactions of ligands in cancer immunotherapy
Continued emergence of SARS-CoV-2 variants highlights importance of sequencing for accurate COVID-19 tracking and surveillance
The acquisition allows full-scale entry into the global life sciences business
Northumbria University team hopes research will lead to more energy-efficient phone and TV screens
The Synthetic Brain Project is using AI models powered by the Cambridge-1 supercomputer
The company seeks to become a global centre of excellence for whole genome sequencing
Nobel prize winning CRISPR technology to be applied in development of genetically engineered animal models
The agreement will provide prevalidated hepatocytes for use on innovative organ-on-a-chip range